What's on?

The Telethon: to take place on 7 and 8 December 2012 with the help of Inserm researchers

03 Dec 2012 | By INSERM (Newsroom) | Event | France

“Oser vaincre” (Dare to win) is the slogan for the Telethon 2012 campaign that will start on December 7 and 8.  Three million people in France are affected by 6,000 different rare diseases. These diseases, mostly genetic and disabling, had remained largely unknown for a long time. The aim of the Telethon is to put these diseases back in the limelight, to provide good quality care for those who suffer from them, to provide suitable support and obtain concrete solutions to help them cope with the diseases by actively supporting research.

Several Inserm researchers are currently working on these rare diseases.Some of them will take part in the 30-hour live Telethon programme and will present the results of their research. They will be available to answer any questions you want to ask between now and Friday.

The personalities below will take part in the Telethon:


Marisol Corral Debrinsky and José-Alain Sahel from theInstituteofVision
Marc Peschanski and Xavier Nissan from Istem
Marina Cavazzana and Alain Fischer
Martine Barkats, Thomas Voit and Laurent Servais from theInstituteofMyology
Nicolas Lévy
Philippe Moullier and Guylène Le Meur

The press releases from these teams are available.

Identification of a recurrent chromosomal anomaly in neural cells derived from pluripotent stem cells (ES and iPS).

The cause of blindness has been identified for certain forms of deaf/blind disorders

On 6 December 2012, Patrizia Paterlini Bréchot’s team published an article demonstrating that it was possible to obtain a prenatal diagnosis of genetic diseases from a simple blood sample.

Researcher Contact

Marisol Corral Debrinski et José Alain Sahel
Unité Inserm 968 “Institut de la vision ”

Martine Barkats et Thomas Voit
Unité Inserm 974 – Thérapies des maladies du muscle strié

Marina Cavazzana-Calvo et Alain Fischer
U’nité 768 – Développement normal et pathologique du système immunitaire

Phillipe Moullier
Unité 1089 -Thérapie génique translationnelle pour les maladies neuromusculaires et de la rétine

Nicolas Levy
Unité Inserm 910 -Génétique médicale et génomique fonctionnelle ”

Marc Peschanski et Xavier Nissan
Unité Inserm U861 -Institut des cellules souches pour le traitement et l’étude des maladies monogéniques (IStem)